Hologic Sees Q1 EPS $0.92-$0.97 Vs $0.95 Est.; Revenue $960M-$985M Vs $1.02B Est.; FY24 EPS $3.90-$4.10 Vs $3.91 Est.; Revenue $3.92B-$4.02B Vs $4.02B Est.
Portfolio Pulse from Benzinga Newsdesk
Hologic has provided its financial guidance for Q1 and FY24, expecting Q1 EPS of $0.92-$0.97 and revenue of $960M-$985M, and FY24 EPS of $3.90-$4.10 and revenue of $3.92B-$4.02B. The company expects total organic constant currency revenue excluding COVID to be within its long-term 5% to 7% growth framework for FY24. The guidance is based on a full year non-GAAP tax rate of approximately 19.75%, and diluted shares outstanding of approximately 239 million for the full year.
November 09, 2023 | 9:06 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Hologic's Q1 and FY24 guidance is slightly below estimates. However, the company expects organic constant currency revenue excluding COVID to grow within its long-term 5% to 7% framework for FY24.
Hologic's guidance for Q1 and FY24 is slightly below estimates, which could negatively impact the stock. However, the company's expectation of 5% to 7% growth in organic constant currency revenue excluding COVID for FY24 could offset this negative impact, leading to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100